Assuntos
Continuidade da Assistência ao Paciente/organização & administração , Transplante de Órgãos/efeitos adversos , Transplante de Órgãos/métodos , Complicações Pós-Operatórias/terapia , Feminino , Seguimentos , Rejeição de Enxerto/prevenção & controle , Sobrevivência de Enxerto , Humanos , Imunossupressores/uso terapêutico , Masculino , Papel do Profissional de Enfermagem , Transplante de Órgãos/mortalidade , Educação de Pacientes como Assunto , Cuidados Pós-Operatórios/métodos , Complicações Pós-Operatórias/mortalidade , Imunologia de Transplantes , Resultado do TratamentoRESUMO
In more than 35 years of experience with heart transplantation, improvements in patient selection, surgical techniques, organ preservation, and postoperative management have increased survival rates and reduced complications. However, a number of significant complications continue, limiting the benefit of heart transplantation as the long-term solution for patients. Current survival rates are 83% at 1 year and 72% at 5 years, with 50% of patients surviving 9.4 years or more. Recipient and donor characteristics influence survival outcome. Primary graft dysfunction is the most frequent cause of death during the first 30 days. The function of the transplanted heart allows return to pre-illness activities, though denervation limits peak exercise capacity. Advances in immunosuppressive medications have decreased the incidence and severity of rejection, though only recently have shown promise in attenuating the incidence of cardiac graft vasculopathy, the major complication limiting long-term graft function. This review addresses current outcomes and the short- and long-term complications of heart transplantation.
